Detalles de la búsqueda
1.
Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study.
Cancer Metab
; 11(1): 6, 2023 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37202813
Resultados
1 -
1
de 1
1
Próxima >
>>